206 related articles for article (PubMed ID: 36291610)
1. Label-Free Quantitative Proteomics Analysis of Adriamycin Selected Multidrug Resistant Human Lung Cancer Cells.
Efeoglu E; Henry M; Clynes M; Meleady P
Biomolecules; 2022 Oct; 12(10):. PubMed ID: 36291610
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis to dissect mitoxantrone resistance-associated proteins in a squamous lung carcinoma.
Murphy L; Clynes M; Keenan J
Anticancer Res; 2007; 27(3A):1277-84. PubMed ID: 17593620
[TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line.
Keenan J; Murphy L; Henry M; Meleady P; Clynes M
Proteomics; 2009 Mar; 9(6):1556-66. PubMed ID: 19242932
[TBL] [Abstract][Full Text] [Related]
4. Altered cell cycle response of drug-resistant lung carcinoma cells to doxorubicin.
O'Loughlin C; Heenan M; Coyle S; Clynes M
Eur J Cancer; 2000 Jun; 36(9):1149-60. PubMed ID: 10854949
[TBL] [Abstract][Full Text] [Related]
5. The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems.
Cleary I; Doherty G; Moran E; Clynes M
Biochem Pharmacol; 1997 May; 53(10):1493-502. PubMed ID: 9260877
[TBL] [Abstract][Full Text] [Related]
6. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
[TBL] [Abstract][Full Text] [Related]
7. Isolation from a human MDR lung cell line of multiple clonal subpopulations which exhibit significantly different drug resistance.
Heenan M; O'Driscoll L; Cleary I; Connolly L; Clynes M
Int J Cancer; 1997 May; 71(5):907-15. PubMed ID: 9180164
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.
NicAmhlaoibh R; Heenan M; Cleary I; Touhey S; O'Loughlin C; Daly C; Nuñez G; Scanlon KJ; Clynes M
Int J Cancer; 1999 Jul; 82(3):368-76. PubMed ID: 10399954
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Proteomic Analysis of Cellular Resistance to the Nanoparticle Abraxane.
Zhao M; Li H; Bu X; Lei C; Fang Q; Hu Z
ACS Nano; 2015 Oct; 9(10):10099-112. PubMed ID: 26324059
[TBL] [Abstract][Full Text] [Related]
10. Enhanced in vitro invasiveness and drug resistance with altered gene expression patterns in a human lung carcinoma cell line after pulse selection with anticancer drugs.
Liang Y; O'Driscoll L; McDonnell S; Doolan P; Oglesby I; Duffy K; O'Connor R; Clynes M
Int J Cancer; 2004 Sep; 111(4):484-93. PubMed ID: 15239124
[TBL] [Abstract][Full Text] [Related]
11. Guajadial reverses multidrug resistance by inhibiting ABC transporter expression and suppressing the PI3K/Akt pathway in drug-resistant breast cancer cells.
Li Y; Zhai Z; Li H; Wang X; Huang Y; Su X
Chem Biol Interact; 2019 May; 305():98-104. PubMed ID: 30929998
[TBL] [Abstract][Full Text] [Related]
12. Activity of the dietary flavonoid, apigenin, against multidrug-resistant tumor cells as determined by pharmacogenomics and molecular docking.
Saeed M; Kadioglu O; Khalid H; Sugimoto Y; Efferth T
J Nutr Biochem; 2015 Jan; 26(1):44-56. PubMed ID: 25459885
[TBL] [Abstract][Full Text] [Related]
13. Comparison of LC-MS/MS-based targeted proteomics and conventional analytical methods for monitoring breast cancer resistance protein expression.
Li H; Meng F; Jiang L; Ren Y; Qiu Z; Yu P; Peng J
Life Sci; 2019 Aug; 231():116548. PubMed ID: 31181228
[TBL] [Abstract][Full Text] [Related]
14. Identification of Up- and Down-Regulated Proteins in Pemetrexed-Resistant Human Lung Adenocarcinoma: Flavin Reductase and Calreticulin Play Key Roles in the Development of Pemetrexed-Associated Resistance.
Chou HC; Chen JY; Lin DY; Wen YF; Lin CC; Lin SH; Lin CH; Chung TW; Liao EC; Chen YJ; Wei YS; Tsai YT; Chan HL
J Proteome Res; 2015 Nov; 14(11):4907-20. PubMed ID: 26452990
[TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-resistant variants of human prostate cancer cell lines DU 145, PC-3, PPC-1, and TSU-PR1: characterization of biochemical determinants of antineoplastic drug sensitivity.
David-Beabes GL; Overman MJ; Petrofski JA; Campbell PA; de Marzo AM; Nelson WG
Int J Oncol; 2000 Dec; 17(6):1077-86. PubMed ID: 11078791
[TBL] [Abstract][Full Text] [Related]
16. Comparative proteomic analysis of protein methylation provides insight into the resistance of hepatocellular carcinoma to 5-fluorouracil.
Liu Z; Wang Q; Mao J; Wang K; Fang Z; Miao QR; Ye M
J Proteomics; 2020 May; 219():103738. PubMed ID: 32198070
[TBL] [Abstract][Full Text] [Related]
17. [Inhibition of ABC-transporter(s)' function in non-small cell lung cancer cells by platinum drugs].
Bogush TA; Konukhova AV; Ravcheeva AB; Zabotina TN; Kadagidze ZG; Bogush EA; Komov DV; Polotskiĭ BE; Laktionov KK; Davydov MI
Antibiot Khimioter; 2003; 48(10):11-5. PubMed ID: 15004974
[TBL] [Abstract][Full Text] [Related]
18. Gefitinib reverses chemotherapy resistance in gefitinib-insensitive multidrug resistant cancer cells expressing ATP-binding cassette family protein.
Yang CH; Huang CJ; Yang CS; Chu YC; Cheng AL; Whang-Peng J; Yang PC
Cancer Res; 2005 Aug; 65(15):6943-9. PubMed ID: 16061679
[TBL] [Abstract][Full Text] [Related]
19. KRAS and EGFR Mutations Differentially Alter ABC Drug Transporter Expression in Cisplatin-Resistant Non-Small Cell Lung Cancer.
Jaromi L; Csongei V; Vesel M; Abdelwahab EMM; Soltani A; Torok Z; Smuk G; Sarosi V; Pongracz JE
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065402
[TBL] [Abstract][Full Text] [Related]
20. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function.
Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC
Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
